Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response
{{output}}
Background: One of the commonly used systemic agents for the treatment of aggressive fibromatosis is the anti-oestrogen drug tamoxifen. However, data on efficacy and optimum methods of response assessment are limited, consisting ... ...
